Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Completed

Conditions: Cost-Benefit Analysis; Influenza Vaccine

Treatments: Drug: Flu Vaccine

Study type: Observational

Funder types: Other

Identifiers

NCT06304038

2018

Details and patient eligibility

About

Flu vaccination, as well as being effective to prevent seasonal influenza, decreases staff illness and absenteeism and reduces costs resulting from loss of productivity. Despite the effectiveness of flu vaccination, the seasonal coverage among healthcare workers is usually low. The aim of this retrospective observational study is to analyze the vaccination coverage rate among all employees (healthcare workers and administrative staff) of a large teaching hospital in Rome during the 2017-2018 influenza season, to perform a cost-consequence analysis of influenza vaccination (by evaluating the absenteeism due to illness in the epidemic period), and to assess the impact of vaccination in terms of both costs and sick days.

Enrollment: 5,483 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthcare workers at Fondazione Policlinico Universitario "A.Gemelli" IRCCS

Exclusion criteria

• Healthcare workers not working at Fondazione Policlinico Universitario "A.Gemelli" IRCCS

Trial design

5,483 participants in 2 patient groups

Vaccinated subjects

Description:

Healthcare workers that received quadrivalent split inactivated non-adjuvanted flu vaccine Fluarix Tetra in a single administration

Treatment:

Drug: Flu Vaccine

Unvaccinated subjects

Description:

Healthcare workers that did not received flu vaccine